Company news

Century Therapeutics, Inc. news in 2025

Century Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Initial Statement of Beneficial Ownership (Form 3)

December 11, 2025

Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

December 9, 2025

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

November 25, 2025

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 13, 2025

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

November 13, 2025

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

October 14, 2025

Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

August 22, 2025

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

August 14, 2025

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

May 28, 2025

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

April 28, 2025

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

April 15, 2025

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

March 19, 2025

Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders

January 20, 2025

Decks in 2025